175 related articles for article (PubMed ID: 37108258)
1. Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson's Disease.
Chang KH; Liu CH; Wang YR; Lo YS; Chang CW; Wu HC; Chen CM
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108258
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
5. Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease.
Scheffels JF; Fröhlich L; Kalbe E; Kessler J
J Neurol Sci; 2020 May; 412():116735. PubMed ID: 32087430
[TBL] [Abstract][Full Text] [Related]
6. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.
van Steenoven I; Aarsland D; Hurtig H; Chen-Plotkin A; Duda JE; Rick J; Chahine LM; Dahodwala N; Trojanowski JQ; Roalf DR; Moberg PJ; Weintraub D
Mov Disord; 2014 Dec; 29(14):1809-15. PubMed ID: 25381961
[TBL] [Abstract][Full Text] [Related]
7. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: Pilot study.
Khedr EM; Mohamed KO; Ali AM; Hasan AM
Restor Neurol Neurosci; 2020; 38(1):55-66. PubMed ID: 31815705
[TBL] [Abstract][Full Text] [Related]
8. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of lipocalin-2 in patients with Parkinson's disease.
Xiong M; Qian Q; Liang X; Wei YD
Neurol Sci; 2022 Mar; 43(3):1755-1759. PubMed ID: 34455500
[TBL] [Abstract][Full Text] [Related]
10. Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).
Mollenhauer B; Zimmermann J; Sixel-Döring F; Focke NK; Wicke T; Ebentheuer J; Schaumburg M; Lang E; Friede T; Trenkwalder C;
Mov Disord; 2019 Jan; 34(1):67-77. PubMed ID: 30468694
[TBL] [Abstract][Full Text] [Related]
11. Predictors of cognitive impairment in an early stage Parkinson's disease cohort.
Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y
Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708
[TBL] [Abstract][Full Text] [Related]
12. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
13. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
[TBL] [Abstract][Full Text] [Related]
14. Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.
Bezdicek O; Červenková M; Moore TM; Stepankova Georgi H; Sulc Z; Wolk DA; Weintraub DA; Moberg PJ; Jech R; Kopecek M; Roalf DR
Assessment; 2020 Dec; 27(8):1960-1970. PubMed ID: 29929376
[TBL] [Abstract][Full Text] [Related]
15. Uric acid: The role in the pathophysiology and the prediction in the diagnosis of Parkinson's disease: A Turkish-based study.
Ari BC; Tur EK; Domac FM; Kenangil GO
Ideggyogy Sz; 2022 Jan; 75(1-02):51-59. PubMed ID: 35112521
[TBL] [Abstract][Full Text] [Related]
16. [Cognitive dysfuctions associated with essential tremor and Parkinson's disease].
Chen J; Yao J; Wu Y; Chen Y; Mao C; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2412-6. PubMed ID: 25400045
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease.
Chuang YH; Lu AT; Paul KC; Folle AD; Bronstein JM; Bordelon Y; Horvath S; Ritz B
J Parkinsons Dis; 2019; 9(2):389-400. PubMed ID: 30958317
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.
Suratos CTR; Saranza GRM; Sumalapao DEP; Jamora RDG
J Clin Neurosci; 2018 Aug; 54():156-160. PubMed ID: 29907384
[TBL] [Abstract][Full Text] [Related]
19. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ
J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247
[TBL] [Abstract][Full Text] [Related]
20. Evolution of prodromal parkinsonian features in a cohort of
Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
